Literature DB >> 12913767

Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities.

Hilmar Wisplinghoff1, Harald Seifert, Sandra M Tallent, Tammy Bischoff, Richard P Wenzel, Michael B Edmond.   

Abstract

BACKGROUND: We identified the predominant pathogens and antimicrobial susceptibilities of nosocomial bloodstream isolates in pediatric patients in the US Prospective surveillance for nosocomial bloodstream infections at 49 hospitals during a 6-year period [Surveillance and Control of Pathogens of Epidemiologic Importance (SCOPE)] detected 22 609 bloodstream infections, of which 3432 occurred in patients < or =16 years of age.
RESULTS: Gram-positive organisms accounted for 65% of cases, Gram-negative organisms accounted for 24% of cases and 11% were caused by fungi. The overall crude mortality was 14% (475 of 3432) but notably higher for infections caused by Candida spp. and Pseudomonas aeruginosa, 20 and 29%, respectively. The most common organisms were coagulase-negative staphylococci (43%), enterococci, Staphylococcus aureus and Candida spp. (each, 9%). The mean interval between admission and infection averaged 21 days for coagulase-negative staphylococci, 25 days for S. aureus and Candida spp., 32 days for Klebsiella spp. and 34 days for Enterococcus spp. The proportion of methicillin-resistant S. aureus increased from 10% in 1995 to 29% in 2001. Vancomycin-resistance was seen in 1% of Enterococcus faecalis and in 11% of Enterococcus faecium isolates.
CONCLUSION: Nosocomial BSI occurred predominantly in very young and/or critically ill children. Gram-positive pathogens predominated across all ages, and increasing antimicrobial resistance was observed in pediatric patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12913767     DOI: 10.1097/01.inf.0000078159.53132.40

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  75 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia.

Authors:  Ganesh Kumarachandran; Jennifer Kristie Johnson; Debbie-Ann Shirley; Eileen Graffunder; Emily L Heil
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

3.  Extended Infusion of Piperacillin/Tazobactam in Children.

Authors:  Chad A Knoderer; Lauren C Karmire; Katie L Andricopulos; Kristen R Nichols
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

Review 4.  Quorum-quenching microbial infections: mechanisms and implications.

Authors:  Y-h Dong; L-y Wang; L-H Zhang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-07-29       Impact factor: 6.237

5.  Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species.

Authors:  Megan E Reller; Amanda B Mallonee; Nicole P Kwiatkowski; William G Merz
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

6.  Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner.

Authors:  Daniel E Dulek; Dawn C Newcomb; Kasia Goleniewska; Jaqueline Cephus; Weisong Zhou; Sara Reiss; Shinji Toki; Fei Ye; Rinat Zaynagetdinov; Taylor P Sherrill; Timothy S Blackwell; Martin L Moore; Kelli L Boyd; Jay K Kolls; R Stokes Peebles
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

7.  Pediatric multicenter evaluation of the Verigene gram-negative blood culture test for rapid detection of inpatient bacteremia involving gram-negative organisms, extended-spectrum beta-lactamases, and carbapenemases.

Authors:  K V Sullivan; B Deburger; S S Roundtree; C A Ventrola; D L Blecker-Shelly; J E Mortensen
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

8.  Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.

Authors:  Hanan K Munayyer; Paul A Mann; Andrew S Chau; Taisa Yarosh-Tomaine; Jonathan R Greene; Roberta S Hare; Larry Heimark; Robert E Palermo; David Loebenberg; Paul M McNicholas
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  A 7-year study of bloodstream infections in an English children's hospital.

Authors:  James W Gray
Journal:  Eur J Pediatr       Date:  2004-07-06       Impact factor: 3.183

10.  Nosocomial Infections among Pediatric Patients with Neoplastic Diseases.

Authors:  Peninnah Oberdorfer; Natthida Pongwilairat; Charles H Washington
Journal:  Int J Pediatr       Date:  2009-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.